A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs ...
Hosted on MSN
Tumor byproduct blocks immune cells from fighting cancer, offering new treatment target
A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback